Related Experiment Videos
Interleukin-6 and "complex" cardiac myxoma
Y Mochizuki1, Y Okamura, H Iida
1Department of Thoracic and Cardiovascular Surgery, Dokkyo University School of Medicine, Tochigi, Japan. mochi@dokkyomed.ac.jp
The Annals of Thoracic Surgery
|October 13, 1998
Summary
A rare complex cardiac myxoma case presented with constitutional symptoms due to excess interleukin-6. Surgical removal of the tumor normalized interleukin-6 levels, indicating its role in the condition.
Area of Science:
- Cardiology
- Oncology
- Immunology
Background:
- Cardiac myxomas are typically benign tumors, but complex types can present with systemic symptoms.
- Constitutional signs in complex cardiac myxomas are often linked to cytokine overproduction.
- Interleukin-6 (IL-6) is implicated in the pathogenesis of systemic manifestations of cardiac myxomas.
Observation:
- A rare case of complex cardiac myxoma was documented.
- The patient exhibited pronounced constitutional signs.
- Immunohistochemical analysis revealed strong interleukin-6 positivity within the myxoma tissue.
Findings:
- Elevated serum interleukin-6 levels were observed in the patient.
- Surgical resection of the cardiac myxoma led to a significant decrease in serum IL-6.
- Serum IL-6 levels remained undetectable post-surgery for two years.
Implications:
- This case highlights the significant role of interleukin-6 in the systemic effects of complex cardiac myxomas.
- It suggests that IL-6 levels can serve as a biomarker for disease activity and treatment response.
- The findings support the complete surgical excision of cardiac myxomas to manage associated constitutional symptoms.